Glax­o­SmithK­line R&D vet Min Li nabs $100M to launch a Bob Nelsen-backed start­up fo­cused on Chi­na’s bur­geon­ing neu­ro mar­ket

In re­cent years we’ve seen a whole string of Chi­na-based biotech star­tups gain im­pres­sive back­ing as they kick­start­ed new com­pa­nies with big plans in on­col­o­gy …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER